Literature DB >> 10886202

Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome.

F Roufosse1, L Schandené, C Sibille, K Willard-Gallo, B Kennes, A Efira, M Goldman, E Cogan.   

Abstract

Idiopathic hypereosinophilic syndrome (HES) and Gleich's syndrome are related disorders characterized by persistent or recurrent hypereosinophilia of unknown origin. Elevated IgE levels and polyclonal hypergammaglobulinaemia are considered as markers of benign outcome in this setting as they are generally associated with predominant cutaneous manifestations and favourable response to glucocorticoid therapy. In a previous study, we identified a clonal population of CD3-CD4+ Th2-like lymphocytes secreting interleukin (IL)-5 and IL-4 in peripheral blood of a patient fulfilling the diagnostic criteria of HES with associated serum hyper-IgE. We now extend this observation by describing identical findings in three additional patients, and we compare their clinical and biological parameters with five other patients with HES. Chromosomal abnormalities were detected in purified CD3-CD4+ Th2 cells from three patients, among whom one developed anaplastic null cell lymphoma. We therefore suggest that a careful search for T-lymphocyte clonality and cytogenetic changes should be included in the work-up of HES for adequate management.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886202     DOI: 10.1046/j.1365-2141.2000.02097.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  30 in total

1.  BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics.

Authors:  Yorick Sandberg; Ellen J van Gastel-Mol; Brenda Verhaaf; King H Lam; Jacques J M van Dongen; Anton W Langerak
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

2.  Hypereosinophilia in a patient with invasive thymoma with clonal T-lymphocyte expansion expressing CD4, CD8, and CD25 antigens.

Authors:  Masahiko Sumi; Kosuke Nunoda; Tomonori Mizutani; Yuko Ishii; Akihiko Gotoh; Yukihiko Kimura; Yasuhiro Suga; Tatsuo Ohira; Kuniharu Miyajima; Hiromi Serizawa; Kiyoshi Mukai; Harubumi Kato; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

Review 3.  Advances in diagnosis and treatment of eosinophilia.

Authors:  Javed Sheikh; Peter F Weller
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

Review 4.  Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations.

Authors:  Florence Roufosse
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

5.  Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome.

Authors:  Amy D Klion; Rojelio Mejia; Edward W Cowen; Kennichi C Dowdell; Kieron Dunleavy; Gary A Fahle; Nicole Holland-Thomas; Irina Maric; Stefania Pittaluga; Mark Raffeld; Carlo Santos; Maryalice Stetler-Stevenson; Tammy Krogmann; Amber N Shatzer; Siu-Ping Turk; Yuzhi Yin; Liqiang Xi; Calman Prussin; Jeffrey I Cohen
Journal:  Blood       Date:  2013-03-21       Impact factor: 22.113

Review 6.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

7.  New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.

Authors:  T Berki; M Dávid; B Bóné; H Losonczy; J Vass; P Németh
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

8.  Idiopathic hypereosinophilic syndrome: a rare cause of erythroderma.

Authors:  Vikram K Mahajan; Ravinder Singh; Karaninder S Mehta; Pushpinder S Chauhan; Saurabh Sharma; Mrinal Gupta; Ritu Rawat
Journal:  J Dermatol Case Rep       Date:  2014-12-31

9.  CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder.

Authors:  Guillaume Lefèvre; Marie-Christine Copin; Christophe Roumier; Hélène Aubert; Martine Avenel-Audran; Nathalie Grardel; Stéphanie Poulain; Delphine Staumont-Sallé; Julien Seneschal; Gilles Salles; Kamel Ghomari; Louis Terriou; Christian Leclech; Chafika Morati-Hafsaoui; Franck Morschhauser; Olivier Lambotte; Félix Ackerman; Jacques Trauet; Sandrine Geffroy; Florent Dumezy; Monique Capron; Catherine Roche-Lestienne; Alain Taieb; Pierre-Yves Hatron; Sylvain Dubucquoi; Eric Hachulla; Lionel Prin; Myriam Labalette; David Launay; Claude Preudhomme; Jean-Emmanuel Kahn
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

Review 10.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.